Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Jul;88(1):186–192. doi: 10.1172/JCI115276

Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.

P B Chapman 1, A N Houghton 1
PMCID: PMC296019  PMID: 2056117

Abstract

Anti-idiotypic MAb were raised in syngeneic mice against a mouse MAb recognizing GD3 ganglioside (MAb R24). Two anti-idiotypic MAb, designated BEC2 and BEC3, recognized distinct determinants on MAb R24 that mapped near or within the GD3-binding site. New Zealand white rabbits, which express GD3 on normal tissues, were immunized with either BEC2, BEC3, or control MAb FLOPC-21. All rabbits developed high and equivalent titers of antibodies against mouse immunoglobulins. Immunization with BEC2 and BEC3 induced rabbit antibodies expressing R24 idiotype as demonstrated by their ability to inhibit BEC2 binding to R24. Antibodies (IgG and IgM) reacting with GD3 developed in five of eight rabbits immunized with BEC2 but not in rabbits immunized with BEC3 or with control MAb. Serum antibodies against GD3 did not cross-react with other gangliosides. These results show that MAb BEC2 can mimic GD3 ganglioside and can induce antibodies against GD3 ganglioside despite expression of GD3 on normal rabbit tissue.

Full text

PDF
186

Images in this article

190Image
on p.190
190Image
on p.190

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cahan L. D., Irie R. F., Singh R., Cassidenti A., Paulson J. C. Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7629–7633. doi: 10.1073/pnas.79.24.7629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chapman P. B., Lonberg M., Houghton A. N. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity. Cancer Res. 1990 Mar 1;50(5):1503–1509. [PubMed] [Google Scholar]
  3. Cheresh D. A., Honsik C. J., Staffileno L. K., Jung G., Reisfeld R. A. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5155–5159. doi: 10.1073/pnas.82.15.5155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dippold W. G., Lloyd K. O., Li L. T., Ikeda H., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6114–6118. doi: 10.1073/pnas.77.10.6114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Endo T., Scott D. D., Stewart S. S., Kundu S. K., Marcus D. M. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol. 1984 Apr;132(4):1793–1797. [PubMed] [Google Scholar]
  6. Furukawa K., Yamaguchi H., Oettgen H. F., Old L. J., Lloyd K. O. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Cancer Res. 1989 Jan 1;49(1):191–196. [PubMed] [Google Scholar]
  7. Graus F., Cordon-Cardo C., Houghton A. N., Melamed M. R., Old L. J. Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibody. Brain Res. 1984 Dec 17;324(1):190–194. doi: 10.1016/0006-8993(84)90642-5. [DOI] [PubMed] [Google Scholar]
  8. Herlyn D., Ross A. H., Koprowski H. Anti-idiotypic antibodies bear the internal image of a human tumor antigen. Science. 1986 Apr 4;232(4746):100–102. doi: 10.1126/science.3952496. [DOI] [PubMed] [Google Scholar]
  9. Houghton A. N., Real F. X., Davis L. J., Cordon-Cardo C., Old L. J. Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. J Exp Med. 1987 Mar 1;165(3):812–829. doi: 10.1084/jem.165.3.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iwamori M., Nagai Y. A new chromatographic approach to the resolution of individual gangliosides. Ganglioside mapping. Biochim Biophys Acta. 1978 Feb 27;528(2):257–267. [PubMed] [Google Scholar]
  11. Iwamori M., Nagai Y. Comparative study on ganglioside compositions of various rabbit tissues. Tissue-specificity in ganglioside molecular species of rabbit thymus. Biochim Biophys Acta. 1981 Aug 24;665(2):214–220. doi: 10.1016/0005-2760(81)90005-9. [DOI] [PubMed] [Google Scholar]
  12. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  13. Kato T., Takazoe I., Okuda K. Protection of mice against the lethal toxicity of a lipopolysaccharide (LPS) by immunization with anti-idiotype antibody to a monoclonal antibody to lipid A from Eikenella corrodens LPS. Infect Immun. 1990 Feb;58(2):416–420. doi: 10.1128/iai.58.2.416-420.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kennedy R. C., Zhou E. M., Lanford R. E., Chanh T. C., Bona C. A. Possible role of anti-idiotypic antibodies in the induction of tumor immunity. J Clin Invest. 1987 Nov;80(5):1217–1224. doi: 10.1172/JCI113195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kundu S. K., Marcus D. M., Veh R. W. Preparation and properties of antibodies to GD3 and GM1 gangliosides. J Neurochem. 1980 Jan;34(1):184–188. doi: 10.1111/j.1471-4159.1980.tb04638.x. [DOI] [PubMed] [Google Scholar]
  16. Livingston P. O., Ritter G., Srivastava P., Padavan M., Calves M. J., Oettgen H. F., Old L. J. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. Cancer Res. 1989 Dec 15;49(24 Pt 1):7045–7050. [PubMed] [Google Scholar]
  17. McNamara M. K., Ward R. E., Kohler H. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. Science. 1984 Dec 14;226(4680):1325–1326. doi: 10.1126/science.6505692. [DOI] [PubMed] [Google Scholar]
  18. O'Shannessy D. J., Dobersen M. J., Quarles R. H. A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties. Immunol Lett. 1984;8(5):273–277. doi: 10.1016/0165-2478(84)90008-7. [DOI] [PubMed] [Google Scholar]
  19. Real F. X., Houghton A. N., Albino A. P., Cordon-Cardo C., Melamed M. R., Oettgen H. F., Old L. J. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res. 1985 Sep;45(9):4401–4411. [PubMed] [Google Scholar]
  20. Rubinstein L. J., Goldberg B., Hiernaux J., Stein K. E., Bona C. A. Idiotype-antiidiotype regulation. V. The requirement for immunization with antigen or monoclonal antiidiotypic antibodies for the activation of beta 2 leads to 6 and beta 2 leads to 1 polyfructosan-reactive clones in BALB/c mice treated at birth with minute amounts of anti-A48 idiotype antibodies. J Exp Med. 1983 Oct 1;158(4):1129–1144. doi: 10.1084/jem.158.4.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schreiber J. R., Patawaran M., Tosi M., Lennon J., Pier G. B. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. J Immunol. 1990 Feb 1;144(3):1023–1029. [PubMed] [Google Scholar]
  22. Sekine M., Ariga T., Miyatake T., Kase R., Suzuki A., Yamakawa T. An interspecies comparison of gangliosides and neutral glycolipids in adrenal glands. J Biochem. 1985 Apr;97(4):1219–1227. doi: 10.1093/oxfordjournals.jbchem.a135167. [DOI] [PubMed] [Google Scholar]
  23. Stein K. E., Söderström T. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med. 1984 Oct 1;160(4):1001–1011. doi: 10.1084/jem.160.4.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tai T., Cahan L. D., Tsuchida T., Saxton R. E., Irie R. F., Morton D. L. Immunogenicity of melanoma-associated gangliosides in cancer patients. Int J Cancer. 1985 May 15;35(5):607–612. doi: 10.1002/ijc.2910350507. [DOI] [PubMed] [Google Scholar]
  25. Tai T., Kawashima I., Furukawa K., Lloyd K. O. Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3. Arch Biochem Biophys. 1988 Jan;260(1):51–55. doi: 10.1016/0003-9861(88)90423-7. [DOI] [PubMed] [Google Scholar]
  26. Tai T., Paulson J. C., Cahan L. D., Irie R. F. Ganglioside GM2 as a human tumor antigen (OFA-I-1). Proc Natl Acad Sci U S A. 1983 Sep;80(17):5392–5396. doi: 10.1073/pnas.80.17.5392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vadhan-Raj S., Cordon-Cardo C., Carswell E., Mintzer D., Dantis L., Duteau C., Templeton M. A., Oettgen H. F., Old L. J., Houghton A. N. Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites. J Clin Oncol. 1988 Oct;6(10):1636–1648. doi: 10.1200/JCO.1988.6.10.1636. [DOI] [PubMed] [Google Scholar]
  28. Viale G., Flamini G., Grassi F., Buffa R., Natali P. G., Pelagi M., Leoni F., Ménard S., Siccardi A. G. Idiotypic replica of an anti-human tumor-associated antigen monoclonal antibody. Analysis of monoclonal Ab1 and Ab3 fine specificity. J Immunol. 1989 Dec 15;143(12):4338–4344. [PubMed] [Google Scholar]
  29. Watanabe T., Pukel C. S., Takeyama H., Lloyd K. O., Shiku H., Li L. T., Travassos L. R., Oettgen H. F., Old L. J. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med. 1982 Dec 1;156(6):1884–1889. doi: 10.1084/jem.156.6.1884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Welte K., Miller G., Chapman P. B., Yuasa H., Natoli E., Kunicka J. E., Cordon-Cardo C., Buhrer C., Old L. J., Houghton A. N. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. J Immunol. 1987 Sep 15;139(6):1763–1771. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES